COGT
Price
$6.79
Change
+$0.80 (+13.36%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
680.86M
66 days until earnings call
XNCR
Price
$9.65
Change
+$0.53 (+5.81%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
686.8M
54 days until earnings call
Interact to see
Advertisement

COGT vs XNCR

Header iconCOGT vs XNCR Comparison
Open Charts COGT vs XNCRBanner chart's image
Cogent Biosciences
Price$6.79
Change+$0.80 (+13.36%)
Volume$41.85K
Capitalization680.86M
Xencor
Price$9.65
Change+$0.53 (+5.81%)
Volume$12.17K
Capitalization686.8M
COGT vs XNCR Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. XNCR commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and XNCR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (COGT: $6.80 vs. XNCR: $9.12)
Brand notoriety: COGT and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 186% vs. XNCR: 55%
Market capitalization -- COGT: $680.86M vs. XNCR: $686.8M
COGT [@Biotechnology] is valued at $680.86M. XNCR’s [@Biotechnology] market capitalization is $686.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 3 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, COGT is a better buy in the short-term than XNCR.

Price Growth

COGT (@Biotechnology) experienced а +25.00% price change this week, while XNCR (@Biotechnology) price change was +17.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($687M) and COGT($681M) have the same market capitalization . COGT YTD gains are higher at: -12.821 vs. XNCR (-60.313). XNCR has higher annual earnings (EBITDA): -161.68M vs. COGT (-284.04M). XNCR has more cash in the bank: 470M vs. COGT (246M). COGT has less debt than XNCR: COGT (17.1M) vs XNCR (67.8M). XNCR has higher revenues than COGT: XNCR (127M) vs COGT (0).
COGTXNCRCOGT / XNCR
Capitalization681M687M99%
EBITDA-284.04M-161.68M176%
Gain YTD-12.821-60.31321%
P/E RatioN/AN/A-
Revenue0127M-
Total Cash246M470M52%
Total Debt17.1M67.8M25%
FUNDAMENTALS RATINGS
COGT vs XNCR: Fundamental Ratings
COGT
XNCR
OUTLOOK RATING
1..100
199
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
6593
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XNCR's Valuation (78) in the Biotechnology industry is in the same range as COGT (81) in the Miscellaneous industry. This means that XNCR’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (71) in the Miscellaneous industry is in the same range as XNCR (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's SMR Rating (94) in the Biotechnology industry is in the same range as COGT (96) in the Miscellaneous industry. This means that XNCR’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (65) in the Miscellaneous industry is in the same range as XNCR (93) in the Biotechnology industry. This means that COGT’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for COGT (100) in the Miscellaneous industry. This means that XNCR’s stock grew significantly faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTXNCR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend about 1 month ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPNMX10.23N/A
N/A
Principal SmallCap Growth I R3
IMOZX26.61N/A
N/A
Voya MidCap Opportunities R6
KCIIX14.20N/A
N/A
Knights of Columbus International Eq I
TSNIX49.76N/A
N/A
T. Rowe Price Science & Tech I
DHFAX13.55N/A
N/A
Diamond Hill Large Cap Concentrated Inv

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+0.22%
CRNX - XNCR
58%
Loosely correlated
+0.59%
BEAM - XNCR
56%
Loosely correlated
-0.87%
ERAS - XNCR
55%
Loosely correlated
+2.61%
BCYC - XNCR
54%
Loosely correlated
+0.59%
CGON - XNCR
54%
Loosely correlated
+0.23%
More